Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy

Clinical trial NCT00727636 · COMPLETED

Trial details

NCT number: NCT00727636
Sponsor: Boston Children's Hospital
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Inflammatory Bowel Disease

Start date: 2008-07-01
Primary completion: 2010-06-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.